Home > Boards > US OTC > Medical - Healthcare > InVivo Therapeutics Holdings Corp (NVIV)

I bought shares of NVIV at initial opening

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
GrannyAnnie Member Profile
 
Followed By 0
Posts 1
Boards Moderated 0
Alias Born 05/16/19
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2019 4:30:59 PM
InVivo Therapeutics Announces Publication of CONTEMPO Registry Study Data in Peer-Reviewed Journal Spinal Cord Business Wire - 7/16/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/12/2019 8:12:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/12/2019 8:06:17 AM
InVivo Therapeutics Announces Postponement of Annual Meeting Business Wire - 7/12/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/5/2019 8:01:02 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/1/2019 6:00:53 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/21/2019 4:08:00 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 6/21/2019 8:02:13 AM
InVivo Therapeutics gibt Vertagung der Hauptversammlung bekannt Business Wire - 6/14/2019 1:21:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 8:06:21 AM
InVivo Therapeutics Announces Adjournment of Annual Meeting Business Wire - 6/14/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2019 7:51:21 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:10:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:07:49 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/30/2019 6:01:28 AM
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal C... Business Wire - 5/29/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/22/2019 5:56:59 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 5/17/2019 4:37:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:03:06 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/25/2019 5:22:49 PM
InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal... Business Wire - 4/17/2019 8:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/15/2019 5:14:37 PM
InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update Business Wire - 4/1/2019 8:15:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/1/2019 8:10:25 AM
GrannyAnnie   Thursday, 05/16/19 12:38:19 PM
Re: None
Post # of 6120 
I bought shares of NVIV at initial opening a few years ago. My cost was $1500.00 and today is worth $5.50. Beware of this company. Someone is getting rich, it is not me.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist